This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Information on how to access Fragmin® (dalteparin sodium) prescribing information and adverse event reporting can be found at the bottom of the page.

Dosing: Thromboprophylaxis in Bedridden Medical Patients

(with medical conditions including, but not limited to: congestive cardiac failure (NYHA class III or IV), acute respiratory failure or acute infection, who also have a predisposing risk factor for venous thromboembolism such as age over 75 years, obesity, cancer or previous history of VTE.)

​​​​​​​Approximately 75% of venous thromboembolism (VTE) cases occur among acutely ill non-surgical patients1

Indication:

For prophylaxis of proximal deep vein thrombosis (DVT) in patients bedridden due to a medical condition, including, but not limited to:2

  • Congestive cardiac failure (NYHA class III or IV)
  • Acute respiratory failure
  • Acute infection
  • Patients who also have a predisposing risk factor for VTE, such as age over 75 years, obesity, cancer or previous history of VTE.

Dosage:

Fragmin 5,000 IU s.c. o.d. for up to 14 days2

Bedridden Thromboprophylaxis

Fragmin Presentations

Discover more

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No